AL-2178 (FID 109980)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-2178 (FID 109980), covering 2012-06-05 to 2012-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye [Phase 3]